JB Chemicals & Pharmaceuticals Limited Cash Flow Conversion Efficiency
JB Chemicals & Pharmaceuticals Limited cash flow conversion efficiency. Based on the latest financial reports, JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) has a cash flow conversion efficiency ratio of 0.095x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.62 Billion ≈ $39.19 Million USD) by net assets (Rs38.06 Billion ≈ $411.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of JB Chemicals & Pharmaceuticals Limited (2006–2026)
Cash flow conversion efficiency of JB Chemicals & Pharmaceuticals Limited from 2006 to 2026. This chart illustrates how JB Chemicals & Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for JB Chemicals & Pharmaceuticals Limited for real-time trading data and today's change.
JB Chemicals & Pharmaceuticals Limited Cash Flow Conversion Ratio Explained
JB Chemicals & Pharmaceuticals Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
JB Chemicals & Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of JB Chemicals & Pharmaceuticals Limited ranked by their cash flow conversion efficiency. Also see market value of JB Chemicals & Pharmaceuticals Limited for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SICC Co. Ltd.
SHG:688234
|
-0.030x |
|
Grupo Simec S.A.B. de C.V
MX:SIMECB
|
-0.007x |
|
De Grey Mining Ltd
AU:DEG
|
0.000x |
|
Hindustan Copper Limited
NSE:HINDCOPPER
|
0.128x |
|
Sinopec Oilfield Service Corp
SHG:600871
|
0.368x |
|
FTI Consulting Inc
NYSE:FCN
|
0.114x |
|
Hongda
SHG:600331
|
-0.083x |
|
Northland Power Inc.
TO:NPI
|
0.037x |
Annual Cash Flow Conversion Efficiency for JB Chemicals & Pharmaceuticals Limited (2006–2026)
The table below shows the annual cash flow conversion efficiency of JB Chemicals & Pharmaceuticals Limited from 2006 to 2026. Review JBCHEPHARM cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs41.59 Billion ≈ $449.80 Million |
Rs7.11 Billion ≈ $76.85 Million |
0.171x | -35.00% |
| 2025-03-31 | Rs34.33 Billion ≈ $371.30 Million |
Rs9.02 Billion ≈ $97.60 Million |
0.263x | -4.02% |
| 2024-03-31 | Rs29.23 Billion ≈ $316.15 Million |
Rs8.01 Billion ≈ $86.58 Million |
0.274x | +8.58% |
| 2023-03-31 | Rs24.80 Billion ≈ $268.24 Million |
Rs6.26 Billion ≈ $67.66 Million |
0.252x | +217.05% |
| 2022-03-31 | Rs21.39 Billion ≈ $231.28 Million |
Rs1.70 Billion ≈ $18.40 Million |
0.080x | -54.17% |
| 2021-03-31 | Rs18.13 Billion ≈ $196.12 Million |
Rs3.15 Billion ≈ $34.04 Million |
0.174x | -9.35% |
| 2020-03-31 | Rs14.38 Billion ≈ $155.51 Million |
Rs2.75 Billion ≈ $29.78 Million |
0.191x | +47.08% |
| 2019-03-31 | Rs14.83 Billion ≈ $160.37 Million |
Rs1.93 Billion ≈ $20.88 Million |
0.130x | +52.83% |
| 2018-03-31 | Rs14.44 Billion ≈ $156.20 Million |
Rs1.23 Billion ≈ $13.31 Million |
0.085x | -41.88% |
| 2017-03-31 | Rs13.66 Billion ≈ $147.71 Million |
Rs2.00 Billion ≈ $21.65 Million |
0.147x | +14.95% |
| 2016-03-31 | Rs10.95 Billion ≈ $118.46 Million |
Rs1.40 Billion ≈ $15.10 Million |
0.128x | +0.15% |
| 2015-03-31 | Rs9.95 Billion ≈ $107.59 Million |
Rs1.27 Billion ≈ $13.70 Million |
0.127x | +1049.86% |
| 2014-03-31 | Rs10.43 Billion ≈ $112.78 Million |
Rs-139.78 Million ≈ $-1.51 Million |
-0.013x | -116.10% |
| 2013-03-31 | Rs10.20 Billion ≈ $110.34 Million |
Rs849.32 Million ≈ $9.19 Million |
0.083x | -90.82% |
| 2012-03-31 | Rs9.70 Billion ≈ $104.90 Million |
Rs8.80 Billion ≈ $95.14 Million |
0.907x | +368.67% |
| 2011-03-31 | Rs6.92 Billion ≈ $74.79 Million |
Rs1.34 Billion ≈ $14.47 Million |
0.194x | -9.87% |
| 2010-03-31 | Rs5.68 Billion ≈ $61.44 Million |
Rs1.22 Billion ≈ $13.19 Million |
0.215x | +10.50% |
| 2009-03-31 | Rs4.69 Billion ≈ $50.71 Million |
Rs911.05 Million ≈ $9.85 Million |
0.194x | +210.91% |
| 2008-03-31 | Rs4.53 Billion ≈ $48.99 Million |
Rs283.11 Million ≈ $3.06 Million |
0.062x | +17.36% |
| 2007-03-31 | Rs4.18 Billion ≈ $45.26 Million |
Rs222.82 Million ≈ $2.41 Million |
0.053x | -21.99% |
| 2006-03-31 | Rs3.30 Billion ≈ $35.73 Million |
Rs225.51 Million ≈ $2.44 Million |
0.068x | -- |
About JB Chemicals & Pharmaceuticals Limited
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; and nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dos… Read more